These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 31765939)
1. Glutamine deprivation counteracts hypoxia-induced chemoresistance. Wappler J; Arts M; Röth A; Heeren RMA; Peter Neumann U; Olde Damink SW; Soons Z; Cramer T Neoplasia; 2020 Jan; 22(1):22-32. PubMed ID: 31765939 [TBL] [Abstract][Full Text] [Related]
2. MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer. Shajahan-Haq AN; Cook KL; Schwartz-Roberts JL; Eltayeb AE; Demas DM; Warri AM; Facey CO; Hilakivi-Clarke LA; Clarke R Mol Cancer; 2014 Oct; 13():239. PubMed ID: 25339305 [TBL] [Abstract][Full Text] [Related]
3. c-Myc is regulated by HIF-2α in chronic hypoxia and influences sensitivity to 5-FU in colon cancer. Wang L; Xue M; Chung DC Oncotarget; 2016 Nov; 7(48):78910-78917. PubMed ID: 27793037 [TBL] [Abstract][Full Text] [Related]
4. Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance. Belisario DC; Kopecka J; Pasino M; Akman M; De Smaele E; Donadelli M; Riganti C Cells; 2020 Dec; 9(12):. PubMed ID: 33291643 [TBL] [Abstract][Full Text] [Related]
5. Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction. Fogal V; Babic I; Chao Y; Pastorino S; Mukthavaram R; Jiang P; Cho YJ; Pingle SC; Crawford JR; Piccioni DE; Kesari S Oncotarget; 2015 Jan; 6(2):1157-70. PubMed ID: 25528767 [TBL] [Abstract][Full Text] [Related]
6. Targeted Inhibition of Glutamine-Dependent Glutathione Metabolism Overcomes Death Resistance Induced by Chronic Cycling Hypoxia. Matschke J; Riffkin H; Klein D; Handrick R; Lüdemann L; Metzen E; Shlomi T; Stuschke M; Jendrossek V Antioxid Redox Signal; 2016 Jul; 25(2):89-107. PubMed ID: 27021152 [TBL] [Abstract][Full Text] [Related]
7. Glycolytic enzyme hexokinase II is a putative therapeutic target in B-cell malignant lymphoma. Nakajima K; Kawashima I; Koshiisi M; Kumagai T; Suzuki M; Suzuki J; Mitsumori T; Kirito K Exp Hematol; 2019 Oct; 78():46-55.e3. PubMed ID: 31560931 [TBL] [Abstract][Full Text] [Related]
8. miR-34a increases cisplatin sensitivity of osteosarcoma cells in vitro through up-regulation of c-Myc and Bim signal. Li QC; Xu H; Wang X; Wang T; Wu J Cancer Biomark; 2017 Dec; 21(1):135-144. PubMed ID: 29060932 [TBL] [Abstract][Full Text] [Related]
9. MYC Expression and Metabolic Redox Changes in Cancer Cells: A Synergy Able to Induce Chemoresistance. Marengo B; Garbarino O; Speciale A; Monteleone L; Traverso N; Domenicotti C Oxid Med Cell Longev; 2019; 2019():7346492. PubMed ID: 31341534 [TBL] [Abstract][Full Text] [Related]
10. Myc-induced glutaminolysis bypasses HIF-driven glycolysis in hypoxic small cell lung carcinoma cells. Munksgaard Thorén M; Vaapil M; Staaf J; Planck M; Johansson ME; Mohlin S; Påhlman S Oncotarget; 2017 Jul; 8(30):48983-48995. PubMed ID: 28430666 [TBL] [Abstract][Full Text] [Related]
11. Sequential treatment with aurora B inhibitors enhances cisplatin-mediated apoptosis via c-Myc. Ma Y; Cao H; Lou S; Shao X; Lv W; Qi X; Liu Y; Ying M; He Q; Yang X J Mol Med (Berl); 2015 Apr; 93(4):427-38. PubMed ID: 25411027 [TBL] [Abstract][Full Text] [Related]
12. Causes and Consequences of A Glutamine Induced Normoxic HIF1 Activity for the Tumor Metabolism. Kappler M; Pabst U; Weinholdt C; Taubert H; Rot S; Kaune T; Kotrba J; Porsch M; Güttler A; Bache M; Krohn K; Bull F; Riemann A; Wickenhauser C; Seliger B; Schubert J; Al-Nawas B; Thews O; Grosse I; Vordermark D; Eckert AW Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554283 [TBL] [Abstract][Full Text] [Related]
13. Forkhead Box R2 Knockdown Decreases Chemoresistance to Cisplatin via MYC Pathway in Bladder Cancer. Li Y; Zu X; Hu X; Wang L; He W Med Sci Monit; 2019 Nov; 25():8928-8939. PubMed ID: 31761897 [TBL] [Abstract][Full Text] [Related]